Reply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors

S. Novello; G. V. Scagliotti; R. Rosell; M. A. Socinski; J. Brahmer; J. Atkins; C. Pallares; R. Burgess; L. Tye; P. Selaru; E. Wang; R. Chao; R. Govindan

doi:10.1038/sj.bjc.6605629

Reply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors

S. Novello
, G. V. Scagliotti
, R. Rosell
, M. A. Socinski
, J. Brahmer
, J. Atkins
, C. Pallares
, R. Burgess
, L. Tye
, P. Selaru
, E. Wang
, R. Chao
, R. Govindan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1311
Number of pages	1
Journal	British Journal of Cancer
Volume	102
Issue number	8
DOIs	https://doi.org/10.1038/sj.bjc.6605629
State	Published - Apr 2010

Access to Document

10.1038/sj.bjc.6605629

Cite this

Novello, S., Scagliotti, G. V., Rosell, R., Socinski, M. A., Brahmer, J., Atkins, J., Pallares, C., Burgess, R., Tye, L., Selaru, P., Wang, E., Chao, R., & Govindan, R. (2010). Reply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors. British Journal of Cancer, 102(8), 1311. https://doi.org/10.1038/sj.bjc.6605629

@article{f03a57f966ee4476a9274087ceaa62ce,

title = "Reply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors",

author = "S. Novello and Scagliotti, \{G. V.\} and R. Rosell and Socinski, \{M. A.\} and J. Brahmer and J. Atkins and C. Pallares and R. Burgess and L. Tye and P. Selaru and E. Wang and R. Chao and R. Govindan",

year = "2010",

month = apr,

doi = "10.1038/sj.bjc.6605629",

language = "English",

volume = "102",

pages = "1311",

journal = "British Journal of Cancer",

issn = "0007-0920",

number = "8",

}

TY - JOUR

T1 - Reply

T2 - Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors

AU - Novello, S.

AU - Scagliotti, G. V.

AU - Rosell, R.

AU - Socinski, M. A.

AU - Brahmer, J.

AU - Atkins, J.

AU - Pallares, C.

AU - Burgess, R.

AU - Tye, L.

AU - Selaru, P.

AU - Wang, E.

AU - Chao, R.

AU - Govindan, R.

PY - 2010/4

Y1 - 2010/4

UR - https://www.scopus.com/pages/publications/77950862996

U2 - 10.1038/sj.bjc.6605629

DO - 10.1038/sj.bjc.6605629

M3 - Letter

AN - SCOPUS:77950862996

SN - 0007-0920

VL - 102

SP - 1311

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 8

ER -

Reply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors

Access to Document

Other files and links

Cite this